{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:53:31Z","timestamp":1793357611931,"version":"4.5.0"},"reference-count":224,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473473"],"award-info":[{"award-number":["81473473"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023A1515012663"],"award-info":[{"award-number":["2023A1515012663"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["KYQD2023307"],"award-info":[{"award-number":["KYQD2023307"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Liver Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.livres.2026.03.001","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:20:47Z","timestamp":1773829247000},"page":"133-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["From bench to bedside: Molecular mechanisms, diagnostic tools, and therapeutic strategies in liver fibrosis"],"prefix":"10.1016","volume":"10","author":[{"given":"Zhen","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhao","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanglong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6471-0893","authenticated-orcid":false,"given":"Guoxin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.livres.2026.03.001_bib1","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJMra2403308","article-title":"Noninvasive assessment of liver fibrosis","volume":"393","author":"Castera","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.livres.2026.03.001_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1039\/D5MH01447F","article-title":"Illuminating liver fibrosis: recent progress in the design and applications of highly sensitive fluorescent probes","volume":"13","author":"Lv","year":"2026","journal-title":"Mater Horiz"},{"key":"10.1016\/j.livres.2026.03.001_bib4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cgh.2025.02.035","article-title":"Novel noninvasive tests for liver fibrosis: moving beyond simple tests in metabolic dysfunction-associated steatotic liver disease","volume":"24","author":"Grady","year":"2026","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib5","article-title":"Understanding the cellular interactome of non-alcoholic fatty liver disease","volume":"4","author":"Wallace","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.livres.2026.03.001_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155380","article-title":"Hepatocyte Ninjurin2 promotes hepatic stellate cell activation and liver fibrosis through the IGF1R\/EGR1\/PDGF-BB signaling pathway","volume":"140","author":"Wang","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.livres.2026.03.001_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41419-024-06509-9","article-title":"The m6A reader IGF2BP2 regulates glycolytic metabolism and mediates histone lactylation to enhance hepatic stellate cell activation and liver fibrosis","volume":"15","author":"Zhou","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.livres.2026.03.001_bib8","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.drudis.2021.12.012","article-title":"Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis","volume":"27","author":"Baghaei","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.livres.2026.03.001_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.livres.2025.01.005","article-title":"Bile acids and their receptors in hepatic immunity","volume":"9","author":"Fiorucci","year":"2025","journal-title":"Liver Res"},{"key":"10.1016\/j.livres.2026.03.001_bib10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jhep.2023.03.038","article-title":"An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH","volume":"79","author":"Tacke","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib11","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","volume":"36","author":"Horn","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2026.03.001_bib12","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis.","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib13","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/jcp.31029","article-title":"Stellate cell in hepatic inflammation and acute injury","volume":"238","author":"Rani","year":"2023","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.livres.2026.03.001_bib14","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.1002\/ptr.7959","article-title":"Extracellular matrix turnover: phytochemicals target and modulate the dual role of matrix metalloproteinases (MMPs) in liver fibrosis","volume":"37","author":"Sabir","year":"2023","journal-title":"Phytother Res"},{"key":"10.1016\/j.livres.2026.03.001_bib15","doi-asserted-by":"crossref","DOI":"10.1007\/s11357-025-01952-8","article-title":"Targeted clearance of senescent cells alleviates alcohol-associated liver disease by restoring cellular function and immune balance","author":"Tian","year":"2025","journal-title":"GeroScience"},{"key":"10.1016\/j.livres.2026.03.001_bib16","article-title":"GDF15 is associated with hepatocellular senescence and correlates with mortality in patients with alcohol-associated hepatitis","volume":"7","author":"Rubio-Tom\u00e1s","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1016\/j.livres.2026.03.001_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13806","article-title":"Immunotherapeutic approach to reduce senescent cells and alleviate senescence-associated secretory phenotype in mice","volume":"22","author":"Shrestha","year":"2023","journal-title":"Aging Cell"},{"key":"10.1016\/j.livres.2026.03.001_bib18","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1053\/j.gastro.2025.06.010","article-title":"Senescence, aging and disease throughout the gastrointestinal system","volume":"169","author":"Ferreira-Gonzalez","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2026.03.001_bib19","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.7150\/thno.106597","article-title":"Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions","volume":"15","author":"Yan","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.livres.2026.03.001_bib20","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2019.11.013","article-title":"Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice","volume":"72","author":"Xiang","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib21","article-title":"Decreased absolute number of peripheral regulatory T cells in patients with idiopathic retroperitoneal fibrosis","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.livres.2026.03.001_bib22","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41419-024-07063-0","article-title":"Iron chelation as a new therapeutic approach to prevent senescence and liver fibrosis progression","volume":"15","author":"Amengual","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.livres.2026.03.001_bib23","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.tips.2025.03.008","article-title":"Targeting AMPK as a potential treatment for hepatic fibrosis in MASLD","volume":"46","author":"Palomer","year":"2025","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.livres.2026.03.001_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2025.101548","article-title":"MFAP4 deficiency attenuates liver fibrosis by regulating hepatic stellate cell fate through inhibition of the FAK\/PI3K\/NF\u03baB signaling pathway","volume":"19","author":"Liu","year":"2025","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib25","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.livres.2026.03.001_bib26","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/HEP.0000000000001093","article-title":"Central role for cholangiocyte pathobiology in cholestatic liver diseases","volume":"82","author":"Jalan-Sakrikar","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2026.03.001_bib27","first-page":"765","article-title":"Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat","volume":"76","author":"Desmouli\u00e8re","year":"1997","journal-title":"Lab Invest"},{"key":"10.1016\/j.livres.2026.03.001_bib28","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jcmgh.2024.01.005","article-title":"Cellular interactions and crosstalk facilitating biliary fibrosis in cholestasis","volume":"17","author":"Ceci","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib29","doi-asserted-by":"crossref","first-page":"E3297","DOI":"10.1073\/pnas.1400062111","article-title":"Origin of myofibroblasts in the fibrotic liver in mice","volume":"111","author":"Iwaisako","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.livres.2026.03.001_bib30","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1172\/JCI88845","article-title":"Mesothelin\/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.livres.2026.03.001_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/j.gastro.2014.05.001","article-title":"The portal fibroblast: not just a poor man\u2019s stellate cell","volume":"147","author":"Wells","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2026.03.001_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib33","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1053\/j.gastro.2025.03.010","article-title":"Regulation of hepatic stellate cell phenotypes in metabolic dysfunction-associated steatohepatitis","volume":"169","author":"Kisseleva","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2026.03.001_bib34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jcmgh.2023.09.008","article-title":"The origin and fate of liver myofibroblasts","volume":"17","author":"Kim","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib35","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41580-024-00716-0","article-title":"Fibroblast and myofibroblast activation in normal tissue repair and fibrosis","volume":"25","author":"Younesi","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.livres.2026.03.001_bib36","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186420","article-title":"MASH: the nexus of metabolism, inflammation, and fibrosis","volume":"135","author":"Steinberg","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.livres.2026.03.001_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41536-024-00359-x","article-title":"A two-way street - cellular metabolism and myofibroblast contraction","volume":"9","author":"Noom","year":"2024","journal-title":"NPJ Regen Med"},{"key":"10.1016\/j.livres.2026.03.001_bib38","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.stem.2025.10.002","article-title":"Tissue regeneration: unraveling strategies for resolving pathological fibrosis","volume":"32","author":"Li","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.livres.2026.03.001_bib39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib40","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1002\/hep.31987","article-title":"Single-cell transcriptomic analysis reveals a hepatic stellate cell-activation roadmap and myofibroblast origin during liver fibrosis in mice","volume":"74","author":"Yang","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2026.03.001_bib41","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/hep.32456","article-title":"Portal fibroblasts with mesenchymal stem cell features form a reservoir of proliferative myofibroblasts in liver fibrosis","volume":"76","author":"Lei","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2026.03.001_bib42","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2101270118","article-title":"Immunotherapy-based targeting of MSLN+ activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis","volume":"118","author":"Nishio","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.livres.2026.03.001_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/apt.15773","article-title":"Review article: the signalling and functional role of the extracellular matrix in the development of liver fibrosis","volume":"52","author":"Villesen","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.livres.2026.03.001_bib44","doi-asserted-by":"crossref","first-page":"G272","DOI":"10.1152\/ajpgi.00379.2019","article-title":"Matrix stiffness and shear stresses modulate hepatocyte functions in a fibrotic liver sinusoidal model","volume":"320","author":"Li","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.livres.2026.03.001_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.574276","article-title":"Immunomodulatory role of the extracellular matrix within the liver disease microenvironment","volume":"11","author":"McQuitty","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.livres.2026.03.001_bib46","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3803\/EnM.2024.1984","article-title":"Irisin attenuates hepatic stellate cell activation and liver fibrosis in bile duct ligation mice model and improves mitochondrial dysfunction","volume":"39","author":"Lai","year":"2024","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.livres.2026.03.001_bib47","article-title":"Transforming growth factor \u03b2 latency: a mechanism of cytokine storage and signalling regulation in liver homeostasis and disease","volume":"4","author":"Li","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.livres.2026.03.001_bib48","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.joca.2014.11.002","article-title":"The emerging role of endothelin-1 in the pathogenesis of subchondral bone disturbance and osteoarthritis","volume":"23","author":"Sin","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.livres.2026.03.001_bib49","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1053\/j.gastro.2004.01.060","article-title":"A cut above the rest? MMP-8 and liver fibrosis gene therapy","volume":"126","author":"Iredale","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2026.03.001_bib50","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jare.2020.05.010","article-title":"Implications of hydrogen sulfide in liver pathophysiology: mechanistic insights and therapeutic potential","volume":"27","author":"Sun","year":"2020","journal-title":"J Adv Res"},{"key":"10.1016\/j.livres.2026.03.001_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120754","article-title":"Electrochemical biosensors for MMP-9 in hepatitis B liver inflammation","volume":"580","author":"Alharbi","year":"2026","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.livres.2026.03.001_bib52","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1080\/10428190500126463","article-title":"Importance of plasma matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinase (TIMP) in development of fibrosis in agnogenic myeloid metaplasia","volume":"46","author":"Wang","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.livres.2026.03.001_bib53","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cccn.2004.06.028","article-title":"Differential expression of matrix metalloproteinases in viral and non-viral chronic liver diseases","volume":"349","author":"Ljumovic","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.livres.2026.03.001_bib54","article-title":"Effect of serum MMP-7 on the diagnostic accuracy of biliary atresia: systematic review and meta-analysis","volume":"16","author":"Wang","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.livres.2026.03.001_bib55","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1600-0560.2009.01188.x","article-title":"Matrix metalloproteinase-26 is present more frequently in squamous cell carcinomas of immunosuppressed compared with immunocompetent patients","volume":"36","author":"Kuivanen","year":"2009","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.livres.2026.03.001_bib56","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41401-021-00666-9","article-title":"The adipokine orosomucoid alleviates adipose tissue fibrosis via the AMPK pathway","volume":"43","author":"Wang","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.livres.2026.03.001_bib57","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1053\/jhep.2002.35279","article-title":"Apoptosis of human hepatic myofibroblasts promotes activation of matrix metalloproteinase-2","volume":"36","author":"Preaux","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2026.03.001_bib58","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3390\/ijms17060868","article-title":"Role of matrix metalloproteinases in photoaging and photocarcinogenesis","volume":"17","author":"Pittayapruek","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2026.03.001_bib59","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3390\/cells11020304","article-title":"Endolysosomal cation channels and lung disease","volume":"11","author":"Spix","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.livres.2026.03.001_bib60","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.3390\/ijms23136894","article-title":"Matrix metalloproteinases and their inhibitors in pulmonary fibrosis: EMMPRIN\/CD147 comes into play","volume":"23","author":"Chuli\u00e1-Peris","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2026.03.001_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/cddiscovery.2017.36","article-title":"Nuclear matrix metalloproteinases: functions resemble the evolution from the intracellular to the extracellular compartment","volume":"3","author":"Xie","year":"2017","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.livres.2026.03.001_bib62","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1165\/rcmb.2017-0223OC","article-title":"Upregulation and nuclear location of MMP28 in alveolar epithelium of idiopathic pulmonary fibrosis","volume":"59","author":"Maldonado","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.livres.2026.03.001_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114472","article-title":"Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis","volume":"161","author":"Shan","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.livres.2026.03.001_bib64","article-title":"The potential role of serum tissue inhibitor of metalloproteinase-2 (TIMP-2) as a biomarker of fibrosis in patients with metabolic dysfunction-associated fatty liver disease (MAFLD)","volume":"17","author":"Tahseen","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.livres.2026.03.001_bib65","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.matbio.2017.11.011","article-title":"Matrix metalloproteinase functions in hepatic injury and fibrosis","volume":"68\u201369","author":"Roderfeld","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.livres.2026.03.001_bib66","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.3390\/ijms21144906","article-title":"Noninvasive assessment of liver fibrosis: current and future clinical and molecular perspectives","volume":"21","author":"Masuzaki","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2026.03.001_bib67","article-title":"Macrophages: subtypes, distribution, polarization, immunomodulatory functions, and therapeutics","volume":"6","author":"Peng","year":"2025","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.livres.2026.03.001_bib68","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41423-025-01298-3","article-title":"Liver macrophages: development, dynamics, and functions","volume":"22","author":"Nusse","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.livres.2026.03.001_bib69","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jhep.2024.06.016","article-title":"Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation","volume":"81","author":"Taru","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib70","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/path.5275","article-title":"Bone marrow-derived macrophage contributes to fibrosing steatohepatitis through activating hepatic stellate cells","volume":"248","author":"Han","year":"2019","journal-title":"J Pathol"},{"key":"10.1016\/j.livres.2026.03.001_bib71","article-title":"The versatility of macrophage heterogeneity in liver fibrosis","volume":"13","author":"Gao","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.livres.2026.03.001_bib72","doi-asserted-by":"crossref","first-page":"eadv2106","DOI":"10.1126\/scitranslmed.adv2106","article-title":"Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction-associated steatohepatitis","volume":"17","author":"Shi","year":"2025","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.livres.2026.03.001_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157349","article-title":"Spermidine enhances macrophages anti-inflammatory and regenerative functions by improving mitochondrial fitness","volume":"148","author":"Liu","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.livres.2026.03.001_bib74","article-title":"Key role of macrophages in the progression of hepatic fibrosis","volume":"9","author":"Ran","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.livres.2026.03.001_bib75","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1248\/bpb.b24-00035","article-title":"Group IVA phospholipase A2 in collagen-producing cells promotes high-fat diet-induced infiltration of inflammatory cells into the liver by upregulating the expression of MCP-1","volume":"47","author":"Kishinaka","year":"2024","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.livres.2026.03.001_bib76","first-page":"634","article-title":"TIMP-1 promotes expression of MCP-1 and macrophage migration by inducing Fli-1 in experimental liver fibrosis","volume":"12","author":"Huang","year":"2024","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315292","article-title":"Activated hepatic stellate cells in hepatocellular carcinoma: their role as a potential target for future therapies","volume":"23","author":"Ali","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2026.03.001_bib78","doi-asserted-by":"crossref","first-page":"G543","DOI":"10.1152\/ajpgi.00262.2020","article-title":"AICAR and compound C negatively modulate HCC-induced primary human hepatic stellate cell activation in vitro","volume":"320","author":"B\u00f6ttcher","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.livres.2026.03.001_bib79","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.semcancer.2023.10.003","article-title":"From shape-shifting embryonic cells to oncology: the fascinating history of epithelial mesenchymal transition","volume":"96","author":"Akhurst","year":"2023","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.livres.2026.03.001_bib80","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00109-020-01926-7","article-title":"Comprehensive characterization of hepatocyte-derived extracellular vesicles identifies direct miRNA-based regulation of hepatic stellate cells and DAMP-based hepatic macrophage IL-1\u03b2 and IL-17 upregulation in alcoholic hepatitis mice","volume":"98","author":"Eguchi","year":"2020","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.livres.2026.03.001_bib81","article-title":"Mechanobiology of portal hypertension","volume":"5","author":"Felli","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.livres.2026.03.001_bib82","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3350\/cmh.2024.0022","article-title":"Liver sinusoidal endothelial cell: an important yet often overlooked player in the liver fibrosis","volume":"30","author":"Qu","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib83","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/HEP.0000000000000207","article-title":"The evolving role of liver sinusoidal endothelial cells in liver health and disease","volume":"78","author":"McConnell","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2026.03.001_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108372","article-title":"Endotheliopathy in the metabolic syndrome: mechanisms and clinical implications","volume":"244","author":"Furuta","year":"2023","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.livres.2026.03.001_bib85","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166731","article-title":"Hepatocyte-specific CCAAT\/enhancer binding protein \u03b1 restricts liver fibrosis progression","volume":"134","author":"Yan","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.livres.2026.03.001_bib86","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jhep.2019.02.012","article-title":"Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease","volume":"70","author":"Hammoutene","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib87","article-title":"Portal hypertension in cirrhosis: pathophysiological mechanisms and therapy","volume":"3","author":"Iwakiri","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.livres.2026.03.001_bib88","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s11658-025-00798-4","article-title":"YAP contributes to liver injury through mediating capillarization of liver sinusoidal endothelial cells via GATA6\/eNOS signaling","volume":"30","author":"Wang","year":"2025","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.livres.2026.03.001_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2025.101637","article-title":"Targeting LOXL1-expressing hepatic stellate cell inhibits fibrogenesis and sinusoid angiogenesis via LOXL1\/RUNX1\/VEGFA axis during progression of liver fibrosis","volume":"20","author":"Yan","year":"2026","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib90","article-title":"Endothelial c-Maf prevents MASLD-like liver fibrosis by regulating chromatin accessibility to suppress pathogenic microvascular cell subsets","volume":"7","author":"Winkler","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1016\/j.livres.2026.03.001_bib91","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1038\/s41467-025-59885-x","article-title":"Nucleic acid spheres for treating capillarisation of liver sinusoidal endothelial cells in liver fibrosis","volume":"16","author":"Liu","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.livres.2026.03.001_bib92","article-title":"Altered liver sinusoidal endothelial cells in MASLD and their evolution following lanifibranor treatment","volume":"7","author":"Rautou","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1016\/j.livres.2026.03.001_bib93","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/pathogens9030225","article-title":"Complex cell type-specific roles of autophagy in liver fibrosis and cirrhosis","volume":"9","author":"Hung","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.livres.2026.03.001_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.100973","article-title":"Autophagy in liver diseases: a review","volume":"82","author":"Qian","year":"2021","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.livres.2026.03.001_bib95","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/15548627.2021.1895658","article-title":"The m\u00e9nage \u00e0 trois of autophagy, lipid droplets and liver disease","volume":"18","author":"Filali-Mouncef","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.livres.2026.03.001_bib96","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7269150","article-title":"The role of autophagy and NLRP3 inflammasome in liver fibrosis","volume":"2020","author":"Tao","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.livres.2026.03.001_bib97","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.apsb.2021.07.021","article-title":"Therapeutic regulation of autophagy in hepatic metabolism","volume":"12","author":"Byrnes","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.livres.2026.03.001_bib98","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.immuni.2021.01.018","article-title":"Autophagy in inflammation, infection, and immunometabolism","volume":"54","author":"Deretic","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.livres.2026.03.001_bib99","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41419-022-04593-3","article-title":"The regulation, function, and role of lipophagy, a form of selective autophagy, in metabolic disorders","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.livres.2026.03.001_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121837","article-title":"Exercise against nonalcoholic fatty liver disease: possible role and mechanism of lipophagy","volume":"327","author":"Su","year":"2023","journal-title":"Life Sci"},{"key":"10.1016\/j.livres.2026.03.001_bib101","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1177\/15353702231191197","article-title":"Selective autophagy associated with iron overload aggravates non-alcoholic steatohepatitis via ferroptosis","volume":"248","author":"Honma","year":"2023","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.livres.2026.03.001_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114653","article-title":"Oroxylin A activates ferritinophagy to induce hepatic stellate cell senescence against hepatic fibrosis by regulating cGAS-STING pathway","volume":"162","author":"Sun","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.livres.2026.03.001_bib103","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.molmed.2023.08.001","article-title":"ROS\/RNS as molecular signatures of chronic liver diseases","volume":"29","author":"Che","year":"2023","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.livres.2026.03.001_bib104","article-title":"Reactive oxygen species induce fatty liver and ischemia-reperfusion injury by promoting inflammation and cell death","volume":"13","author":"Tang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.livres.2026.03.001_bib105","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1053\/j.gastro.2019.07.029","article-title":"Fibrogenic activity of MECP2 is regulated by phosphorylation in hepatic stellate cells","volume":"157","author":"Moran-Salvador","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2026.03.001_bib106","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.livres.2026.03.001_bib107","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fcimb.2020.00018","article-title":"Gut microbial dysbiosis is associated with profibrotic factors in liver fibrosis mice","volume":"10","author":"Wan","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.livres.2026.03.001_bib108","first-page":"94","article-title":"The effect of oxidative stress on the autonomic nervous system in patients with liver cirrhosis","volume":"298","author":"Abrahamovych","year":"2020","journal-title":"Georgian Med News"},{"key":"10.1016\/j.livres.2026.03.001_bib109","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.3390\/antiox12122040","article-title":"Extracellular superoxide dismutase attenuates hepatic oxidative stress in nonalcoholic fatty liver disease through the adenosine monophosphate-activated protein kinase activation","volume":"12","author":"Nam","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.livres.2026.03.001_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101191","article-title":"Mechanisms of organ fibrosis: emerging concepts and implications for novel treatment strategies","volume":"92","author":"Lurje","year":"2023","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.livres.2026.03.001_bib111","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s13679-025-00657-5","article-title":"The intriguing roles of cytokines in metabolic dysfunction-associated steatotic liver disease: a narrative review","volume":"14","author":"Vachliotis","year":"2025","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.livres.2026.03.001_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108563","article-title":"Therapeutic potential of stem cells in regeneration of liver in chronic liver diseases: current perspectives and future challenges","volume":"253","author":"Yadav","year":"2024","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.livres.2026.03.001_bib113","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s41232-024-00326-5","article-title":"Regulation of inflammatory diseases via the control of mRNA decay","volume":"44","author":"Yoshinaga","year":"2024","journal-title":"Inflamm Regen"},{"key":"10.1016\/j.livres.2026.03.001_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103314","article-title":"Carbon monoxide-loaded red blood cells ameliorate metabolic dysfunction-associated steatohepatitis progression via enhancing AMP-activated protein kinase activity and inhibiting Kupffer cell activation","volume":"76","author":"Yanagisawa","year":"2024","journal-title":"Redox Biol"},{"key":"10.1016\/j.livres.2026.03.001_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154537","article-title":"The role of Andrographolide in the prevention and treatment of liver diseases","volume":"109","author":"Qin","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.livres.2026.03.001_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121894","article-title":"Therapeutic implications of targeting autophagy and TGF-\u03b2 crosstalk for the treatment of liver fibrosis","volume":"329","author":"Siapoush","year":"2023","journal-title":"Life Sci"},{"key":"10.1016\/j.livres.2026.03.001_bib117","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202300793","article-title":"Role of culinary indian spices in the regulation of TGF-\u03b2 signaling pathway in inflammation-induced liver cancer","volume":"68","author":"Asoka","year":"2024","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.livres.2026.03.001_bib118","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.3390\/cells10092312","article-title":"The TGF-\u03b2\/NADPH oxidases axis in the regulation of liver cell biology in health and disease","volume":"10","author":"Herranz-It\u00farbide","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.livres.2026.03.001_bib119","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.3390\/ijms23116270","article-title":"Smad3 phospho-isoform signaling in nonalcoholic steatohepatitis","volume":"23","author":"Yamaguchi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2026.03.001_bib120","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.7150\/ijbs.89568","article-title":"The role of TGF-\u03b2\/SMAD signaling in hepatocellular carcinoma: from mechanism to therapy and prognosis","volume":"20","author":"Xin","year":"2024","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.livres.2026.03.001_bib121","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.3390\/ijms24043473","article-title":"Expression and function of BMP and activin membrane-bound inhibitor (BAMBI) in chronic liver diseases and hepatocellular carcinoma","volume":"24","author":"Weber","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2026.03.001_bib122","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1007\/s10620-020-06460-7","article-title":"MicroRNA-503 targets mothers against decapentaplegic homolog 7 enhancing hepatic stellate cell activation and hepatic fibrosis","volume":"66","author":"Xie","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.livres.2026.03.001_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176367","article-title":"Arbidol attenuates liver fibrosis and activation of hepatic stellate cells by blocking TGF-\u03b21 signaling","volume":"967","author":"Ren","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.livres.2026.03.001_bib124","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3390\/cells13191651","article-title":"Kisspeptin alleviates human hepatic fibrogenesis by inhibiting TGF\u03b2 signaling in hepatic stellate cells","volume":"13","author":"Prasad","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.livres.2026.03.001_bib125","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s13577-023-01017-y","article-title":"The miR-3074\/BMP7 axis regulates TGF-\u03b2-caused activation of hepatic stellate cells in vitro and CCl4-caused murine liver fibrosis in vivo","volume":"37","author":"Liu","year":"2024","journal-title":"Hum Cell"},{"key":"10.1016\/j.livres.2026.03.001_bib126","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.livres.2026.03.001_bib127","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","article-title":"Shared and distinct mechanisms of fibrosis","volume":"15","author":"Distler","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.livres.2026.03.001_bib128","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mam.2017.11.008","article-title":"PDGF in organ fibrosis","volume":"62","author":"Klinkhammer","year":"2018","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.livres.2026.03.001_bib129","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1535370219898141","article-title":"Mechanisms of liver fibrosis and its role in liver cancer","volume":"245","author":"Dhar","year":"2020","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.livres.2026.03.001_bib130","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jhep.2024.01.036","article-title":"Sex-determining region Y gene promotes liver fibrosis and accounts for sexual dimorphism in its pathophysiology","volume":"80","author":"Wu","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib131","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-75713-6","article-title":"Deletion of platelet-derived growth factor receptor \u03b2 suppresses tumorigenesis in metabolic dysfunction-associated steatohepatitis (MASH) mice with diabetes","volume":"14","author":"Wada","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.livres.2026.03.001_bib132","doi-asserted-by":"crossref","first-page":"7879","DOI":"10.3892\/mmr.2017.7641","article-title":"PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics (Review)","volume":"16","author":"Ying","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.livres.2026.03.001_bib133","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.3390\/cells9092027","article-title":"Targeting cancer associated fibroblasts in liver fibrosis and liver cancer using nanocarriers","volume":"9","author":"Kaps","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.livres.2026.03.001_bib134","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/alcalc\/agz094","article-title":"Platelet-derived growth factor C in alcoholics","volume":"55","author":"Mart\u00edn-Gonz\u00e1lez","year":"2020","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.livres.2026.03.001_bib135","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41419-020-2575-0","article-title":"Roseotoxin B alleviates cholestatic liver fibrosis through inhibiting PDGF-B\/PDGFR-\u03b2 pathway in hepatic stellate cells","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.livres.2026.03.001_bib136","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41591-019-0379-5","article-title":"Platelet GPIb\u03b1 is a mediator and potential interventional target for NASH and subsequent liver cancer","volume":"25","author":"Malehmir","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.livres.2026.03.001_bib137","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1007\/s00259-023-06577-7","article-title":"Platelet-derived growth factor receptor \u03b2-targeted positron emission tomography imaging for the noninvasive monitoring of liver fibrosis","volume":"51","author":"Li","year":"2024","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.livres.2026.03.001_bib138","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1158\/2159-8290.CD-21-0190","article-title":"WNT as a driver and dependency in cancer","volume":"11","author":"Parsons","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.livres.2026.03.001_bib139","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154515","article-title":"\u03b2-Catenin signaling in hepatocellular carcinoma","volume":"132","author":"Xu","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.livres.2026.03.001_bib140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41575-018-0075-9","article-title":"Wnt-\u03b2-catenin signalling in liver development, health and disease","volume":"16","author":"Perugorria","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110851","article-title":"WNT\/\u03b2-catenin signaling in the development of liver cancers","volume":"132","author":"He","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.livres.2026.03.001_bib142","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41575-020-00365-6","article-title":"Maladaptive regeneration - the reawakening of developmental pathways in NASH and fibrosis","volume":"18","author":"Zhu","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib143","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3390\/biomedicines9081014","article-title":"Extra- and intra-cellular mechanisms of hepatic stellate cell activation","volume":"9","author":"Yan","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.livres.2026.03.001_bib144","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jhep.2017.10.017","article-title":"Hedgehog signalling in liver pathophysiology","volume":"68","author":"Machado","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib145","doi-asserted-by":"crossref","first-page":"G720","DOI":"10.1152\/ajpgi.00310.2020","article-title":"Gli2-regulated activation of hepatic stellate cells and liver fibrosis by TGF-\u03b2 signaling","volume":"320","author":"Yan","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.livres.2026.03.001_bib146","article-title":"Adipocyte fatty acid binding protein promotes the onset and progression of liver fibrosis via mediating the crosstalk between liver sinusoidal endothelial cells and hepatic stellate cells","volume":"8","author":"Wu","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.livres.2026.03.001_bib147","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2026.03.001_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113869","article-title":"Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.livres.2026.03.001_bib149","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.7150\/thno.85369","article-title":"Secretome of senescent hepatic stellate cells favors malignant transformation from nonalcoholic steatohepatitis-fibrotic progression to hepatocellular carcinoma","volume":"13","author":"Zhou","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.livres.2026.03.001_bib150","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/PAI.0000000000000724","article-title":"Novel interplay between sonic hedgehog and transforming growth factor-\u03b21 in human nonalcoholic steatohepatitis","volume":"28","author":"Zhou","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.livres.2026.03.001_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104064","article-title":"Unveiling the role of the Hedgehog signaling pathway in chronic liver disease: therapeutic insights and strategies","volume":"29","author":"Nair","year":"2024","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.livres.2026.03.001_bib152","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/bph.15945","article-title":"CK2 blockade alleviates liver fibrosis by suppressing activation of hepatic stellate cells via the Hedgehog pathway","volume":"180","author":"Fan","year":"2023","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.livres.2026.03.001_bib153","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3892\/mmr.2020.11821","article-title":"miR-375 affects the hedgehog signaling pathway by downregulating RAC1 to inhibit hepatic stellate cell viability and epithelial-mesenchymal transition","volume":"23","author":"Liang","year":"2021","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.livres.2026.03.001_bib154","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s12079-023-00775-6","article-title":"Knockdown of Yap attenuates TAA-induced hepatic fibrosis by interaction with hedgehog signals","volume":"17","author":"Zhao","year":"2023","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.livres.2026.03.001_bib155","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41575-021-00571-w","article-title":"Hippo signalling in the liver: role in development, regeneration and disease","volume":"19","author":"Russell","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib156","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jhep.2025.06.002","article-title":"Steatotic liver disease induces YAP\/TAZ-driven cell competition that can suppress tumor initiation","volume":"83","author":"Alguer\u00f3-Nadal","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib157","doi-asserted-by":"crossref","first-page":"eadq2395","DOI":"10.1126\/sciadv.adq2395","article-title":"Noncanonical role of Golgi-associated macrophage TAZ in chronic inflammation and tumorigenesis","volume":"11","author":"Park","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.livres.2026.03.001_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2024.04.005","article-title":"RASSF4 attenuates metabolic dysfunction-associated steatotic liver disease progression via Hippo signaling and suppresses hepatocarcinogenesis","volume":"18","author":"Xu","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib159","article-title":"YAP mediates HIV-related liver fibrosis","volume":"6","author":"Spalding","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.livres.2026.03.001_bib160","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.168476","article-title":"miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progression","volume":"9","author":"Fern\u00e1ndez-Tussy","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.livres.2026.03.001_bib161","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S2468-1253(24)00437-0","article-title":"Staging liver fibrosis and cirrhosis using non-invasive tests in people with chronic hepatitis B to inform WHO 2024 guidelines: a systematic review and meta-analysis","volume":"10","author":"Liguori","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib162","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.3748\/wjg.v27.i34.5753","article-title":"Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease","volume":"27","author":"Wu","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2026.03.001_bib163","doi-asserted-by":"crossref","first-page":"589","DOI":"10.14218\/JCTH.2021.00311","article-title":"Validation of non-invasive fibrosis scores for predicting advanced fibrosis in metabolic-associated fatty liver disease","volume":"10","author":"Chen","year":"2022","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib164","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1038\/s41591-023-02539-6","article-title":"Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis","volume":"29","author":"Sanyal","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.livres.2026.03.001_bib165","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2023.04.002","article-title":"Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease","volume":"79","author":"Kjaergaard","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib166","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jhep.2024.01.014","article-title":"Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease","volume":"80","author":"Younossi","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib167","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.cgh.2021.12.034","article-title":"Low accuracy of FIB-4 and NAFLD fibrosis scores for screening for liver fibrosis in the population","volume":"20","author":"Graupera","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib168","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111905","article-title":"Clinical and molecular biomarkers for diagnosis and staging of NAFLD","volume":"22","author":"Di Mauro","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2026.03.001_bib169","doi-asserted-by":"crossref","first-page":"8139","DOI":"10.3390\/ijms22158139","article-title":"Diagnosis and therapeutic management of liver fibrosis by microRNA","volume":"22","author":"Tadokoro","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2026.03.001_bib170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255672","article-title":"Clinical impact of serum exosomal microRNA in liver fibrosis","volume":"16","author":"Chang","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.livres.2026.03.001_bib171","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/gutjnl-2014-306996","article-title":"Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis","volume":"64","author":"Pirola","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.livres.2026.03.001_bib172","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/gutjnl-2020-322526","article-title":"MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases","volume":"70","author":"Wang","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.livres.2026.03.001_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100700","article-title":"microRNA-122 inhibits hepatic stellate cell proliferation and activation in vitro and represses carbon tetrachloride-induced liver cirrhosis in mice","volume":"27","author":"Ma","year":"2022","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib174","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.3390\/ijms21165677","article-title":"The role of the liver-specific microRNA, miRNA-122 in the HCV replication cycle","volume":"21","author":"Kunden","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2026.03.001_bib175","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.3390\/cells9081767","article-title":"MicroRNA-221: a fine tuner and potential biomarker of chronic liver injury","volume":"9","author":"Markovic","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.livres.2026.03.001_bib176","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1111\/liv.14476","article-title":"Integration of miRNA-regulatory networks in hepatic stellate cells identifies TIMP3 as a key factor in chronic liver disease","volume":"40","author":"Azar","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2026.03.001_bib177","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s10020-020-00207-w","article-title":"Exosomal miR-223 derived from natural killer cells inhibits hepatic stellate cell activation by suppressing autophagy","volume":"26","author":"Wang","year":"2020","journal-title":"Mol Med"},{"key":"10.1016\/j.livres.2026.03.001_bib178","article-title":"Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: diagnostic and mechanistic relevance","volume":"4","author":"Johnson","year":"2022","journal-title":"JHEP Rep"},{"issue":"Suppl 1","key":"10.1016\/j.livres.2026.03.001_bib179","first-page":"S41","article-title":"Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease","volume":"59","author":"Noureddin","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.livres.2026.03.001_bib180","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jhep.2021.11.012","article-title":"MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis","volume":"76","author":"Noureddin","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib181","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jhep.2025.04.026","article-title":"The emerging role of second harmonic generation\/two photon excitation for precision digital analysis of liver fibrosis in MASH clinical trials","volume":"83","author":"Neuschwander-Tetri","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib182","doi-asserted-by":"crossref","first-page":"7714","DOI":"10.1038\/s41467-025-63006-z","article-title":"Serological proteomic characterization for monitoring liver fibrosis regression in chronic hepatitis B patients on treatment","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.livres.2026.03.001_bib183","article-title":"Liver fibrosis progression analyzed with AI predicts renal decline","volume":"7","author":"Sun","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1016\/j.livres.2026.03.001_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.media.2025.103507","article-title":"MERIT: multi-view evidential learning for reliable and interpretable liver fibrosis staging","volume":"102","author":"Liu","year":"2025","journal-title":"Med Image Anal"},{"key":"10.1016\/j.livres.2026.03.001_bib185","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.231461","article-title":"US-based sequential algorithm integrating an AI model for advanced liver fibrosis screening","volume":"311","author":"Chen","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.livres.2026.03.001_bib186","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s12072-021-10294-4","article-title":"Diagnosis of significant liver fibrosis in patients with chronic hepatitis B using a deep learning-based data integration network","volume":"16","author":"Liu","year":"2022","journal-title":"Hepatol Int"},{"key":"10.1016\/j.livres.2026.03.001_bib187","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/HEP.0000000000000908","article-title":"Benchmarking clinical risk prediction algorithms with ensemble machine learning for the noninvasive diagnosis of liver fibrosis in NAFLD","volume":"80","author":"Charu","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2026.03.001_bib188","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"Marcellin","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.livres.2026.03.001_bib189","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","article-title":"Determinants of fibrosis progression and regression in NASH","volume":"68","author":"Schuppan","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib190","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1186\/s12951-024-02824-7","article-title":"Apoptotic vesicles (apoVs) derived from fibroblast-converted hepatocyte-like cells effectively ameliorate liver fibrosis","volume":"22","author":"Zhong","year":"2024","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.livres.2026.03.001_bib191","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.1021\/acs.biomac.4c00691","article-title":"Cholinized-polymer functionalized lipid-based drug carriers facilitate liver fibrosis therapy via ultrafast liver-targeting delivery","volume":"25","author":"Yuan","year":"2024","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.livres.2026.03.001_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124607","article-title":"Sequential system based on ferritin delivery system and cell therapy for modulating the pathological microenvironment and promoting recovery","volume":"664","author":"Xu","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.livres.2026.03.001_bib193","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.cmet.2024.04.020","article-title":"Myocardial infarction accelerates the progression of MASH by triggering immunoinflammatory response and induction of periosti","volume":"36","author":"Xie","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2026.03.001_bib194","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jcmgh.2023.02.005","article-title":"Periostin protects against alcohol-related liver disease by activating autophagy by interacting with protein disulfide isomerase","volume":"15","author":"Zhang","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib195","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/path.5756","article-title":"Periostin deficiency reduces diethylnitrosamine-induced liver cancer in mice by decreasing hepatic stellate cell activation and cancer cell proliferation","volume":"255","author":"Xiao","year":"2021","journal-title":"J Pathol"},{"key":"10.1016\/j.livres.2026.03.001_bib196","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41419-024-06437-8","article-title":"Activated hepatic stellate cell-derived Bmp-1 induces liver fibrosis via mediating hepatocyte epithelial-mesenchymal transition","volume":"15","author":"Wan","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.livres.2026.03.001_bib197","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1021\/acs.molpharmaceut.4c00173","article-title":"Neutrophil-based bionic delivery system breaks through the capillary barrier of liver sinusoidal endothelial cells and inhibits the activation of hepatic stellate cells","volume":"21","author":"Sun","year":"2024","journal-title":"Mol Pharm"},{"key":"10.1016\/j.livres.2026.03.001_bib198","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-020-0342-4","article-title":"Liver regeneration: biological and pathological mechanisms and implications","volume":"18","author":"Michalopoulos","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib199","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.actbio.2023.12.027","article-title":"Collagenase type I and probucol-loaded nanoparticles penetrate the extracellular matrix to target hepatic stellate cells for hepatic fibrosis therapy","volume":"175","author":"Wang","year":"2024","journal-title":"Acta Biomater"},{"key":"10.1016\/j.livres.2026.03.001_bib200","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-67926-6","article-title":"Inhibition of intrahepatic monocyte recruitment by Cenicriviroc and extracellular matrix degradation by MMP1 synergistically attenuate liver inflammation and fibrogenesis in vivo","volume":"14","author":"Geervliet","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.livres.2026.03.001_bib201","article-title":"Scar-degrading endothelial cells as a treatment for advanced liver fibrosis","volume":"10","author":"Zhao","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.livres.2026.03.001_bib202","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.apsb.2022.10.003","article-title":"Synergistic activation of AMPK by AdipoR1\/2 agonist and inhibitor of EDPs-EBP interaction recover NAFLD through enhancing mitochondrial function in mice","volume":"13","author":"Song","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.livres.2026.03.001_bib203","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.actbio.2022.08.065","article-title":"Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy","volume":"152","author":"Zhou","year":"2022","journal-title":"Acta Biomater"},{"key":"10.1016\/j.livres.2026.03.001_bib204","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.livres.2024.11.004","article-title":"Application of mesenchymal stem cells in liver fibrosis and regeneration","volume":"8","author":"Liu","year":"2024","journal-title":"Liver Res"},{"key":"10.1016\/j.livres.2026.03.001_bib205","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s12072-024-10717-y","article-title":"Mesenchymal stem cells-derived exosomes alleviate liver fibrosis by targeting Hedgehog\/SMO signaling","volume":"18","author":"Zong","year":"2024","journal-title":"Hepatol Int"},{"key":"10.1016\/j.livres.2026.03.001_bib206","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.2147\/IJN.S450284","article-title":"BMP7-loaded human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorate liver fibrosis by targeting activated hepatic stellate cells","volume":"19","author":"Zhu","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.livres.2026.03.001_bib207","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ad304d","article-title":"Bioreactor-based stem cell therapy for liver fibrosis","volume":"16","author":"Yan","year":"2024","journal-title":"Biofabrication"},{"key":"10.1016\/j.livres.2026.03.001_bib208","article-title":"Smart microneedle arrays integrating cell-free therapy and nanocatalysis to treat liver fibrosis","volume":"11","author":"Xu","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.livres.2026.03.001_bib209","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.livres.2026.03.001_bib210","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/HEP.0000000000001084","article-title":"Health-related quality of life (HRQL) assessments in a 52-week, double-blind, randomized, placebo-controlled phase III study of resmetirom (MGL-3196) in patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis","volume":"81","author":"Younossi","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2026.03.001_bib211","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.livres.2026.03.001_bib212","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.livres.2026.03.001_bib213","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41575-025-01107-2","article-title":"Interaction of inflammation and portal hypertension in cirrhosis progression","volume":"22","author":"Costa","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.03.001_bib214","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/HEP.0000000000000841","article-title":"Noninvasive liver disease assessment to identify portal hypertension: systematic and narrative reviews supporting the AASLD Practice Guideline","volume":"81","author":"Rockey","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2026.03.001_bib215","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s12072-025-10812-8","article-title":"Carvedilol and traditional nonselective beta blockers for the secondary prophylaxis of variceal hemorrhage and portal hypertension related complications among patients with decompensated cirrhosis: a systematic review and network meta-analysis","volume":"19","author":"Mingpun","year":"2025","journal-title":"Hepatol Int"},{"key":"10.1016\/j.livres.2026.03.001_bib216","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/apt.17824","article-title":"Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant data","volume":"59","author":"Villanueva","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.livres.2026.03.001_bib217","article-title":"EASL postgraduate course report: vascular biology in chronic liver disease and clinical management implications","volume":"7","author":"Rautou","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1016\/j.livres.2026.03.001_bib218","doi-asserted-by":"crossref","first-page":"eadu7596","DOI":"10.1126\/sciadv.adu7596","article-title":"Hepatic hypertension on-a-chip identifies GPR116 as a hydrostatic pressure mechanosensor to regulate vascular injury in cirrhosis","volume":"11","author":"Long","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.livres.2026.03.001_bib219","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00535-025-02317-w","article-title":"Validation of Baveno VII criteria for recompensation in patients with decompensated cirrhosis treated by laparoscopic splenectomy and azygoportal disconnection","volume":"61","author":"Zhou","year":"2026","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.livres.2026.03.001_bib220","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103113","article-title":"Cost-effectiveness of an outreach program for HCC screening in patients with cirrhosis: a microsimulation modeling study","volume":"81","author":"Gurley","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.livres.2026.03.001_bib221","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000535497","article-title":"Surveillance for hepatocellular carcinoma in patients with successfully treated viral disease of the liver: a systematic review","volume":"13","author":"Lani","year":"2024","journal-title":"Liver Cancer"},{"key":"10.1016\/j.livres.2026.03.001_bib222","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.livres.2026.03.001_bib223","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1039\/D5SC06867C","article-title":"A high-throughput N-glycan analysis strategy with targeted mass spectrometry (HTnGQs-target) for liver disease diagnosis","volume":"17","author":"Liu","year":"2025","journal-title":"Chem Sci"},{"key":"10.1016\/j.livres.2026.03.001_bib224","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1053\/j.gastro.2025.08.021","article-title":"Changes in liver disease etiology support a lower alpha-fetoprotein threshold for hepatocellular carcinoma screening","volume":"170","author":"Kim","year":"2026","journal-title":"Gastroenterology"}],"container-title":["Liver Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S254256842600022X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S254256842600022X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:36:46Z","timestamp":1783211806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S254256842600022X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":224,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S254256842600022X"],"URL":"https:\/\/doi.org\/10.1016\/j.livres.2026.03.001","relation":{},"ISSN":["2542-5684"],"issn-type":[{"value":"2542-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From bench to bedside: Molecular mechanisms, diagnostic tools, and therapeutic strategies in liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Liver Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.livres.2026.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Third Affiliated Hospital of Sun Yat-Sen University. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}